Latest Content

In a recent interview with CURE, Nona Baker shared insights from her blood cancer journey that began more than 30 years ago.

Giredestrant improved invasive disease-free survival for people with estrogen receptor-positive early breast cancer compared with standard treatment.

I share how the nurses who cared for my daughter during chemotherapy brought comfort, connection and humanity that carried us through our hardest moments.

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable.

Nona Baker received a diagnosis of essential thrombocythemia in 1991, followed by polycythemia vera in 2004.

Dr. Anne Chiang explains how biomarker testing and molecular profiling personalize lung cancer treatment and compare tissue versus liquid biopsies.

After surviving testicular cancer, I feel like I was given a second chance at life. Although given challenges, I have learned to be resilient and face adversity head-on.

Dr. Ajay Gupta sat down with CURE to explain the basics of gastrointestinal stromal tumors, highlighting what patients with this disease need to know.

The FDA accepted a new drug application for zidesamtinib for previously treated locally advanced or metastatic ROS1-positive non-small cell lung cancer.

I reflect on my brain tumor journey, sharing how gratitude, love and connection with my parents and others strengthened me through difficult times.

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with activating mutations.

The FDA approved Imdelltra after a study showed longer survival compared with chemotherapy in advanced small cell lung cancer.

I never dreamed a stranger could teach me so much about cancer, life and living with gratitude but I'm so glad she did!